398 related articles for article (PubMed ID: 28619524)
1. Molecular determinants of radiosensitivity in normal and tumor tissue: A bioinformatic approach.
Pavlopoulou A; Bagos PG; Koutsandrea V; Georgakilas AG
Cancer Lett; 2017 Sep; 403():37-47. PubMed ID: 28619524
[TBL] [Abstract][Full Text] [Related]
2. Radiogenomics - current status, challenges and future directions.
Andreassen CN; Schack LM; Laursen LV; Alsner J
Cancer Lett; 2016 Nov; 382(1):127-136. PubMed ID: 26828014
[TBL] [Abstract][Full Text] [Related]
3. Radiogenomics: towards a personalized radiation oncology.
Roberson JD; Burnett OL; Robin N
Curr Opin Pediatr; 2016 Dec; 28(6):713-717. PubMed ID: 27552070
[TBL] [Abstract][Full Text] [Related]
4. [Individual response to ionising radiation: What predictive assay(s) to choose?].
Granzotto A; Joubert A; Viau M; Devic C; Maalouf M; Thomas C; Vogin G; Malek K; Colin C; Balosso J; Foray N
C R Biol; 2011 Feb; 334(2):140-57. PubMed ID: 21333944
[TBL] [Abstract][Full Text] [Related]
5. Preface on application of omics technologies in cancer biology and therapy.
Georgakilas AG
Cancer Lett; 2016 Nov; 382(1):A1. PubMed ID: 27765153
[No Abstract] [Full Text] [Related]
6. Modeling Cellular Response in Large-Scale Radiogenomic Databases to Advance Precision Radiotherapy.
Manem VS; Lambie M; Smith I; Smirnov P; Kofia V; Freeman M; Koritzinsky M; Abazeed ME; Haibe-Kains B; Bratman SV
Cancer Res; 2019 Dec; 79(24):6227-6237. PubMed ID: 31558563
[TBL] [Abstract][Full Text] [Related]
7. Individual Response to Ionizing Radiation and Personalized Radiotherapy.
Domina EA; Philchenkov A; Dubrovska A
Crit Rev Oncog; 2018; 23(1-2):69-92. PubMed ID: 29953368
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive molecular tumor profiling in radiation oncology: How it could be used for precision medicine.
Eke I; Makinde AY; Aryankalayil MJ; Ahmed MM; Coleman CN
Cancer Lett; 2016 Nov; 382(1):118-126. PubMed ID: 26828133
[TBL] [Abstract][Full Text] [Related]
9. Identification of a radiation sensitivity gene expression profile in primary fibroblasts derived from patients who developed radiotherapy-induced fibrosis.
Forrester HB; Li J; Leong T; McKay MJ; Sprung CN
Radiother Oncol; 2014 May; 111(2):186-93. PubMed ID: 24835153
[TBL] [Abstract][Full Text] [Related]
10. A multiple genomic data fused SF2 prediction model, signature identification, and gene regulatory network inference for personalized radiotherapy.
He QE; Tong YF; Ye Z; Gao LX; Zhang YZ; Wang L; Song K
Technol Cancer Res Treat; 2020; 19():1533033820909112. PubMed ID: 32329416
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers of radiation exposure: can they predict normal tissue radiosensitivity?
Chua ML; Rothkamm K
Clin Oncol (R Coll Radiol); 2013 Oct; 25(10):610-6. PubMed ID: 23870757
[TBL] [Abstract][Full Text] [Related]
12. Biological basis of radiation sensitivity. Part 2: Cellular and molecular determinants of radiosensitivity.
Rosen EM; Fan S; Goldberg ID; Rockwell S
Oncology (Williston Park); 2000 May; 14(5):741-57; discussion 757-8, 761-6. PubMed ID: 10853463
[TBL] [Abstract][Full Text] [Related]
13. The molecular and cellular basis of radiosensitivity: implications for understanding how normal tissues and tumors respond to therapeutic radiation.
Rosen EM; Fan S; Rockwell S; Goldberg ID
Cancer Invest; 1999; 17(1):56-72. PubMed ID: 10999050
[TBL] [Abstract][Full Text] [Related]
14. Finding the genetic determinants of adverse reactions to radiotherapy.
Rattay T; Talbot CJ
Clin Oncol (R Coll Radiol); 2014 May; 26(5):301-8. PubMed ID: 24702740
[TBL] [Abstract][Full Text] [Related]
15. Genetic variation in normal tissue toxicity induced by ionizing radiation.
Popanda O; Marquardt JU; Chang-Claude J; Schmezer P
Mutat Res; 2009 Jul; 667(1-2):58-69. PubMed ID: 19022265
[TBL] [Abstract][Full Text] [Related]
16. Network-based analysis of prostate cancer cell lines reveals novel marker gene candidates associated with radioresistance and patient relapse.
Seifert M; Peitzsch C; Gorodetska I; Börner C; Klink B; Dubrovska A
PLoS Comput Biol; 2019 Nov; 15(11):e1007460. PubMed ID: 31682594
[TBL] [Abstract][Full Text] [Related]
17. Novel DNA sequence variants in the hHR21 DNA repair gene in radiosensitive cancer patients.
Severin DM; Leong T; Cassidy B; Elsaleh H; Peters L; Venter D; Southey M; McKay M
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1323-31. PubMed ID: 11483345
[TBL] [Abstract][Full Text] [Related]
18. Compromized DNA repair as a basis for identification of cancer radiotherapy patients with extreme radiosensitivity.
Lobachevsky P; Leong T; Daly P; Smith J; Best N; Tomaszewski J; Thompson ER; Li N; Campbell IG; Martin RF; Martin OA
Cancer Lett; 2016 Dec; 383(2):212-219. PubMed ID: 27693457
[TBL] [Abstract][Full Text] [Related]
19. Radiogenomics: using genetics to identify cancer patients at risk for development of adverse effects following radiotherapy.
Kerns SL; Ostrer H; Rosenstein BS
Cancer Discov; 2014 Feb; 4(2):155-65. PubMed ID: 24441285
[TBL] [Abstract][Full Text] [Related]
20. Development of a radiosensitivity gene signature for patients with soft tissue sarcoma.
Tang Z; Zeng Q; Li Y; Zhang X; Ma J; Suto MJ; Xu B; Yi N
Oncotarget; 2017 Apr; 8(16):27428-27439. PubMed ID: 28404969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
